Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers | China | 2015 | Market Analysis
The Chinese surgical hemostat, internal tissue sealant, and adhesion barrier market is dominated by a large number of smaller domestic companies, but has strong potential for larger international companies; despite high price competition and a lack of government reimbursement for these products, the market will undergo considerable expansion through 2023.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for surgical hemostats, internal tissue sealants, and adhesion barriers in China across a 10-year period.
